← Back to Patent Explorer
US4192799A Expired / Lapsed US ⏱️ 0.0 years remaining

Conjugates formed by reacting a prostaglandin mimic compound with a carrier molecule

Assignee: Pharmacia and Upjohn Co
•
Filing: 1977-09-21
•
Granted: 1980-03-11
•
Expires: 1997-09-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for the radioimmunoassay of PGE 1 -type and PGE 2 -type compounds and PGX is disclosed which utilizes antibodies formed against a prostaglandin mimic. Conjugates are disclosed which are formed by attaching a prostaglandin mimic to a carrier molecule. Antibodies are disclosed which are specific against PGE 1 -type and PGE 2 -type compounds, PGH 2 , and PGX. Complexes are disclosed which are formed by binding an antibody raised against a prostaglandin mimic with its corresponding authentic prostaglandin.

Inventors

  • 👤 Francis A. Fitzpatrick

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 17:24
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/88; Y; Y10; Y10S; Y10S530/00; Y10S530/806

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 272 words
A conjugate formed by attaching to a carrier molecule which is a macromolecular immunogen of molecular weight greater than 2000 and less than 500,000, a compound selected from the group ##STR19## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R 3 and R 4 is fluoro only when the other is hydrogen or fluoro; wherein Z 1 is (1) cis--CH═CH--CH 2 --(CH 2 ) g --CH 2 --, (2) cis--CH═CH--CH 2 --(CH 2 ) g --CF 2 --, (3) cis--CH 2 --CH═CH--(CH 2 ) g --CH 2 --, (4) --(CH 2 ) 3 --(CH 2 ) g --CH 2 --, (5) --(CH 2 ) 3 --(CH 2 ) g --CF 2 --, (6) --CH 2 --O--CH 2 --(CH 2 ) g --CH 2 --, (7) --C.tbd.C--CH 2 --(CH 2 ) g --CH 2 --, (8) --CH 2 --C.tbd.C--(CH 2 ) g --CH 2 --, ##STR20## wherein m is one to 5, inclusive; n is zero or one; T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive; and s is zero, one, 2, or 3, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl, with the further proviso that R 7 is ##STR21## wherein T and s are as defined above, only when R 3 and R 4 are hydrogen or methyl, being the same or different; and wherein X 1 is --COOR 1 wherein R 1 is hydrogen or a pharmacologically acceptable cation.
Claim 2
Dependent Claim 272 words
A conjugate formed by attaching to a carrier molecule which is a macromolecular immunogen of molecular weight greater than 2000 and less than 500,000, a compound selected from the group ##STR19## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R 3 and R 4 is fluoro only when the other is hydrogen or fluoro; wherein Z 1 is (1) cis--CH═CH--CH 2 --(CH 2 ) g --CH 2 --, (2) cis--CH═CH--CH 2 --(CH 2 ) g --CF 2 --, (3) cis--CH 2 --CH═CH--(CH 2 ) g --CH 2 --, (4) --(CH 2 ) 3 --(CH 2 ) g --CH 2 --, (5) --(CH 2 ) 3 --(CH 2 ) g --CF 2 --, (6) --CH 2 --O--CH 2 --(CH 2 ) g --CH 2 --, (7) --C.tbd.C--CH 2 --(CH 2 ) g --CH 2 --, (8) --CH 2 --C.tbd.C--(CH 2 ) g --CH 2 --, ##STR20## wherein m is one to 5, inclusive; n is zero or one; T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive; and s is zero, one, 2, or 3, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl, with the further proviso that R 7 is ##STR21## wherein T and s are as defined above, only when R 3 and R 4 are hydrogen or methyl, being the same or different; and wherein X 1 is --COOR 1 wherein R 1 is hydrogen or a pharmacologically acceptable cation.
Claim 3
Dependent Claim 27 words
The conjugate of claim 1 where the carrier molecule is selected from the group natural protein, synthetic polypeptide, and other immunogen of molecular weight greater than 2500.
Claim 4
Dependent Claim 31 words
The conjugate of claim 2 where the carrier molecule is selected from the group mammal or bird albumin, mammal or bird globulin, poly-1-lysine, and polypeptide of molecular weight greater than 2500.
Claim 5
Dependent Claim 21 words
The conjugate of claim 3 where the carrier molecule is selected from the group keyhole limpet hemocyanin and bovine serum albumin.
Claim 6
Dependent Claim 35 words
The conjugate of claim 1 when formed in the presence of a coupling agent selected from the group carbonyl diimidazole, alkylchloroformate where the alkyl is of one through eight carbon atoms, and water soluble carbodiimide.
Claim 7
Dependent Claim 11 words
The conjugate of claim 5 when the coupling agent is 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Claim 8
Dependent Claim 15 words
The conjugate of claim 1 where the PG mimic is a compound of formula IV.
Claim 9
Dependent Claim 15 words
The conjugate of claim 7 where the PG mimic is a 9-deoxy-9-methylene-PGF 1 -type compound.
Claim 10
Dependent Claim 15 words
The conjugate of claim 7 where the PG mimic is a 9-deoxy-9-methylene-PGF 2 -type compound.
Claim 11
Dependent Claim 77 words
The conjugate of claim 7 where the PG mimic is a compound of the formula ##STR22## wherein Z is --CH 2 CH 2 --or cis--CH═CH--; wherein R is hydrogen or a pharmacologically acceptable cation; wherein R 2 and R 3 are hydrogen, methyl, or ethyl; and wherein A is ##STR23## wherein R 4 is hydrogen, methyl, or ethyl with the proviso that R 2 and R 3 are both hydrogen when R 4 is methyl or ethyl.
Claim 12
Dependent Claim 16 words
The conjugate of claim 10 where the PG mimic is a 9-deoxy-9-methylene PGF 1 -type compound.
Claim 13
Dependent Claim 14 words
The conjugate of claim 11 where the PG mimic is 9-deoxy-9-methylene PGF 1 .
Claim 14
Dependent Claim 15 words
The conjugate of claim 10 where the PG mimic is a 9-deoxy-9-methylene-PGF 2 -type compound.
Claim 15
Dependent Claim 13 words
The conjugate of claim 13 where the PG mimic is 9-deoxy-9-methylene-PGF 2 .
Claim 16
Dependent Claim 13 words
The conjugate of claim 13 where the PG mimic is 9-deoxy-9-methylene-15(R)-15-methyl-PGF 2 .
Claim 17
Dependent Claim 13 words
The conjugate of claim 13 where the PG mimic is 9-deoxy-9-methylene-15(S)-15-methyl-PGF 2 .
Claim 18
Dependent Claim 12 words
The conjugate of claim 1 where the PG mimic is (5Z,9α,11α,13E,15S)-9,11-azo-15-hydroxyprosta-5,13-dien-1-oic acid.
Claim 19
Dependent Claim 13 words
The conjugate of claim 1 where the PG mimic is 9-deoxy-6,9α-epoxy-PGF 1 α.

References Cited (Backward Citations)

US3867366A Cited
US3980764A Cited
US4041076A Cited
US3950363A Cited
US4053459A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-03-11 1983-09-10 1984-03-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-03-11 1987-09-10 1988-03-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-03-11 1991-09-10 1992-03-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag